MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0007983
Fido Pharma Private Limited - chemicals and materials in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.59 Cr
▲ 190% YoY
Net profit · FY 2024
₹4.07 Cr
Net margin 19.8%
EBITDA · FY 2024
₹4.89 Cr
EBITDA margin 23.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹6.9 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Fido Pharma Private Limited
Data last updated:
Fido Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 04 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2020PTC085725. Its GSTIN is 06AAECF0417B1ZE (Haryana). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Tejal Ashok Vispute and Parbhat Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Second Floor Of SCO No.45 Sector – 4, Panchkula, Haryana, India – 134112.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.59 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.07 Cr (net margin 19.8%) and EBITDA of ₹4.89 Cr (EBITDA margin 23.8%). Revenue has grown at a compounded annual rate (CAGR) of 114% over three years.
The company is associated with 8 brands, including Lglutathionereducedmanufacturers, Hyaluronicacidmanufacturers, Sodiumhyaluronatemanufacturers, Pediococcus Acidilactici, Trypsin Chymotrypsin and others. As per MCA filings, the company has open charges of ₹6.9 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in November 2020.
Fido Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0007983). For more details, the company can be reached via its website fidopharma.com.
Company details
CIN U24230HR2020PTC085725
Registration Number 085725
Incorporation Date 04 March 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-HR-13-0007983
Recognitions & Rankings of Fido Pharma
Contact details
Fido Pharma Private Limited's registered office is in Panchkula, Haryana. Its website is fidopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSecond Floor Of SCO No.45 Sector – 4, Panchkula, Haryana, India – 134112
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Fido Pharma Private Limited, buy the company report.
Comprehensive company report
Fido Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Fido Pharma operates multiple associated brands including Lglutathionereducedmanufacturers, Hyaluronicacidmanufacturers, and Sodiumhyaluronatemanufacturers. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures enzymes and probiotics for biopharmaceutical, food, and cosmetics applications. | trypsinchymotrypsin.com | |
| Manufactures enzymes and probiotics for biopharmaceutical, fine chemicals, food, and cosmetics sectors. | fidopharma.com | |
| Delivers enzyme solutions and probiotics for biopharmaceutical, fine chemicals, food, and cosmetics industries. | lglutathionereducedmanufacturers.com | |
| Delivers enzyme solutions and probiotics for biopharmaceutical, fine chemicals, food, feed, and cosmetics applications. | hyaluronicacidmanufacturers.com | |
| Delivers enzyme and probiotic solutions for industrial applications in biopharmaceuticals and cosmetics. | sodiumhyaluronatemanufacturers.com | |
| Manufactures enzymes and probiotics for biopharmaceutical, fine chemicals, food, feed, and cosmetics applications. | pediococcusacidilactici.com | |
| Manufactures enzymes and probiotics for health, food, and chemical sectors. | bifidobacteriumspecies.com | |
| Delivers enzyme solutions and probiotics for biopharmaceutical, fine chemicals, food, and cosmetics applications. | pyrroloquinoline.com |
Financials of Fido Pharma Private Limited
FY 2024 filings availableFido Pharma Private Limited reported revenue of ₹20.59 Cr (up 190% YoY) for FY 2024.
Revenue · FY 2024
₹20.59 Cr ▲ 190%
Net profit · FY 2024
₹4.07 Cr margin 19.8%
EBITDA · FY 2024
₹4.89 Cr margin 23.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 190%
3 years · compounded
▲ 114%
EBITDA CAGR growth
1 year
▲ 410%
3 years · compounded
▲ 193%
Revenue has grown at a compounded annual rate (CAGR) of 114% over three years, including 190% growth in the latest year. EBITDA rose 410% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹20.59 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.89 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.8% | ||||
| Net Profit Margin | 19.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fido Pharma Private Limited, buy the company report.
Board of directors of Fido Pharma Private Limited
Fido Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tejal Ashok Vispute Also directs: Meibotan Private Limited | Director | 04 Mar 2020 | 6 Years 7 Months | Current |
| Parbhat Singh Also directs: Kenu Biopharma Private Limited, Meibotan Private Limited | Director | 04 Mar 2020 | 6 Years 7 Months | Current |
| Ritu Raj Singh Also directs: Devssci Healthcare LLP | Director | 30 May 2023 | 3 Years 4 Months | Current |
Auditor
Fido Pharma Private Limited is audited by G S KATARIA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G S KATARIA & ASSOCIATES | FY 2024 | 030079N |
Shareholding
The shareholding of Fido Pharma Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Fido Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101204745 | Others | ₹74.65 Lakh | Open | |
| 04 Jun 2024 | 100956309 | Hdfc Bank Limited | ₹60 Lakh | Open | |
| 16 Feb 2024 | 100863767 | Others | ₹4.95 Cr | Open | |
| 28 Dec 2023 | 100870873 | Hdfc Bank Limited | ₹60 Lakh | Open |
To see the full charge records of Fido Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Fido Pharma Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in November 2020.
Total deals
1
Funding round
1
Disclosed funding
₹49 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Funding round | ₹49 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Fido Pharma Private Limited has 3 court cases on record: 3 filed by Fido Pharma. All cases are pending.
Total cases
3
Filed by the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (1 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Fido Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fido Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fido Pharma has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
6
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECF0417B1ZE | Haryana | Active | 16 Jun 2020 |
| 29AAECF0417B1Z6 | Karnataka | Active | 24 Aug 2023 |
| 19AAECF0417B1Z7 | West Bengal | Active | 02 Sep 2023 |
| 36AAECF0417B1ZB | Telangana | Active | 04 Sep 2023 |
To see the full GST registrations and return filing status of Fido Pharma Private Limited, buy the company report.
Recent activity
Fido Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Ashutosh Ashok Vispute ceased to be Director on 05 Jul 2024.
Charges
A charge with Others amounted to Rs. 74.65 Lakh with Charge ID 101204745 was registered on 30 Sep 2025.
Charges
A charge with Others of Rs. 495.00 Lakh registered on 16 Feb 2024 with Charge ID 100863767 was modified on 18 Jul 2025.
AGM
Fido Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Ashutosh Ashok Vispute ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 60.00 Lakh with Charge ID 100956309 was registered on 04 Jun 2024.
Filing
Fido Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 495.00 Lakh with Charge ID 100863767 was registered on 16 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 60.00 Lakh with Charge ID 100870873 was registered on 28 Dec 2023.
Appointed
Ritu Raj Singh was appointed as Director.
Appointed
Parbhat Singh was appointed as Director.
Appointed
Tejal Ashok Vispute was appointed as Director.
Incorporation
04 Mar 2020
Fido Pharma Private Limited was registered on 04 Mar 2020 with Roc Delhi & aged 6 years 7 months as per MCA records.
Frequently asked questions
Fido Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 04 March 2020 (6+ years old) and is registered under CIN U24230HR2020PTC085725.
Fido Pharma has 3 current directors:
- Tejal Ashok Vispute - Director
- Parbhat Singh - Director
- Ritu Raj Singh - Director
The latest financial statements of Fido Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Fido Pharma is 06AAECF0417B1ZE, registered in Haryana. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 29AAECF0417B1Z6 (Karnataka), 19AAECF0417B1Z7 (West Bengal), 36AAECF0417B1ZB (Telangana).
The CIN (Corporate Identification Number) of Fido Pharma is U24230HR2020PTC085725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fido Pharma has 3 court cases on record: 3 filed by the company. 3 are pending.
Fido Pharma was incorporated on 04 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Fido Pharma has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in November 2020.
Ashutosh Ashok Vispute ceased to be Director on 05 Jul 2024. Ritu Raj Singh was appointed as Director on 30 May 2023. Parbhat Singh was appointed as Director on 04 Mar 2020. Fido Pharma has 4 board changes on record in total.
Yes, Fido Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0007983).